Patents by Inventor Eric Loeser

Eric Loeser has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9334276
    Abstract: The invention relates to a phosphate salt or a nitrate salt of 4-(R)-6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-5-yl-3-fluoro-benzonitrile, especially in crystalline form, and specific forms of these salts, as well as related invention embodiments. The salts and salt forms allow for the prophylactic and/or therapeutic treatment of aldosterone synthase and/or aromatase mediated diseases or disorders.
    Type: Grant
    Filed: January 15, 2013
    Date of Patent: May 10, 2016
    Assignee: Novartis AG
    Inventors: Paul Allen Sutton, Eric Loeser
  • Publication number: 20140364470
    Abstract: The invention relates to a phosphate salt or a nitrate salt of 4-(R)-6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-5-yl-3-fluoro-benzonitrile, especially in crystalline form, and specific forms of these salts, as well as related invention embodiments. The salts and salt forms allow for the prophylactic and/or therapeutic treatment of aldosterone synthase and/or aromatase mediated diseases or disorders.
    Type: Application
    Filed: January 15, 2013
    Publication date: December 11, 2014
    Applicant: Novartis AG
    Inventors: Paul Alan Sutton, Eric Loeser
  • Publication number: 20070135502
    Abstract: Compounds of the formula provide pharmacological agents which are potent agonists of Peroxisome Proliferator-Activated Receptors (PPARs). Accordingly, the compounds of the instant invention are useful for the treatment of conditions mediated by the PPAR receptor activity in mammals. Such conditions include dyslipidemia, hyperlipidemia, hypercholesteremia, atherosclerosis, hypertriglyceridemia, heart failure, myocardial infarction, vascular diseases, cardiovascular diseases, hypertension, obesity, inflammation, arthritis, cancer, Alzheimer's disease, skin disorders, respiratory diseases, ophthalmic disorders, inflammatory bowel diseases, ulcerative colitis and Crohn's disease. The compounds of the present invention are particularly useful in mammals as hypoglycemic agents for the treatment and prevention of conditions in which impaired glucose tolerance, hyperglycemia and insulin resistance are implicated, such as type-1 and type-2 diabetes, and Syndrome X.
    Type: Application
    Filed: January 4, 2007
    Publication date: June 14, 2007
    Inventors: Andrew Bach, Prasad Kapa, George Lee, Eric Loeser, Michael Sabio, James Stanton, Thalaththani Vedananda
  • Publication number: 20050261504
    Abstract: The present invention is directed to a process for preparing intermediates that are useful to prepare certain antibacterial N-formyl hydroxylamine compounds which are peptide deformylase inhibitors. The process makes use a ?-lactarn intermediate. Certain optically pure intermediates are also claimed.
    Type: Application
    Filed: September 18, 2003
    Publication date: November 24, 2005
    Inventors: Prasad Kapa, Xinglong Jiang, Eric Loeser, Joel Slade, Mahavir Prashad, George Lee